Connection

Satish Nadig to Molecular Targeted Therapy

Back to Details
This is a "connection" page, showing publications Satish Nadig has written about Molecular Targeted Therapy.
Satish Nadig
Connection Strength
0.043
Molecular Targeted Therapy
  1. In Situ Pre-Treatment of Vascularized Composite Allografts With a Targeted Complement Inhibitor Protects Against Brain Death and Ischemia Reperfusion Induced Injuries. Front Immunol. 2021; 12:630581.
    View in: PubMed
    Score: 0.043
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.